Objective: This study compared reoperation rates associated with open abdominal aortic aneurysm (AAA) repair (OR) outcomes vs endovascular AAA repair (EVAR).
Reoperation rates after abdominal aortic aneurysm (AAA) repairs should be included in the outcome analysis comparing open repair (OR) and endovascular AAA repair (EVAR). Randomized trial data have shown conflicting results on this issue, which can partly be explained by incongruent definitions of reoperations and their durations of follow-up. The United Kingdom Endovascular Aneurysm Repair trial reported higher rates after EVAR, but reoperations were defined as those relating specifically to the graft and did not include any abdominal complications secondary to laparotomies. 1 The Open Versus Endovascular Repair (OVER) trial evaluated reoperation rates in the United States Veterans Hospital Administration with a definition that included complications relating to laparotomies and found no difference in overall reoperation rates 2 ; however, abdominal complication follow-up was limited to 30 days. The Dutch Randomized Endovascular Aneurysm Management (DREAM) trial included incisional hernias as reoperations and found freedom from reoperation was similar between OR and EVAR until 4 years postoperatively, when EVAR reoperations become significantly greater, 3 but this definition of reoperations for abdominal complications did not include bowel obstructions or any other abdominal wound complications. We sought to elucidate long-term reoperation rates using exhaustive definitions to compare national OR and EVAR performed by the Veterans Hospital Administration health care system. Because of the ready availability of national clinical data, we were able to expediently analyze a large body of data retrospectively. Although the strength of retrospective conclusions is weaker compared with those of the aforementioned prospective data, the previous trials were systematically confounded with respect to the topic of reoperation. We hypothesized that OR would be associated with higher need for reoperation.
METHODS
A retrospective review of the Veterans Affairs Surgical Quality Improvement Program (VASQIP) database was performed, including all AAA repairs from October 1, 2007, to October 1, 2013. Ruptured AAAs were not included in this initial query. The Veterans Health Administration Corporate Data Warehouse was queried for all subsequent operating room procedures performed at a Veterans Affairs medical center after the original date of AAA repair. The Corporate Data Warehouse is a national Veterans Health Administration high-performance intelligence infrastructure designed to compile clinical and administrative data throughout the Department of Veterans Affairs. Stewarded by the Office of Information and Technology, the database emphasizes standardization, consolidation, and streamlining of clinical data systems to optimize accuracy and accessibility of data for the purposes of clinical, administrative, and business research investigations. The data include, but are not limited to, admissions, discharges, diagnoses, procedures, and treatments. Relevant reoperations were then selected from these queries using our inclusion criteria described below. The Washington, DC Veterans Affairs Medical Center Institutional Review Board approved this study and verified that no patient consent was required.
Reoperations were defined as any open or endovascular aortoiliac operation, any femorofemoral bypass, or any axillofemoral bypass. Thrombectomy, endarterectomy, or revision of the femoral arteries was included up to 10 days postoperatively as well as colectomies and any colonoscopies indicated for ischemia. Lower extremity fasciotomies and amputations were included up to 14 days. Specific to those with original OR performed or EVAR with subsequent laparotomy, we included incisional hernia repairs, lyses of adhesions, abdominal wall reconstructions, and small bowel resections at any duration of follow-up, and abdominal wound drainage or débridement up to 6 months. When an unrelated abdominal operation occurred after the original AAA repair, all subsequent abdominal operations were excluded. Specific to those with original EVAR, we included groin wound drainage or débride-ment up to 6 months. Aortoiliac angiograms not accompanied by further intervention were also excluded.
Reoperations were then combined into the following six categories: open vascular reoperations, endovascular reoperations, laparotomy/abdominal interventions, groin wound interventions, bowel ischemia interventions, and lower extremity ischemia interventions (Table I ). The primary outcome was reoperation rates for OR and EVAR. Additional comparisons were made to evaluate reoperations stratified by category and, alternatively, by interval from the original AAA repair. Univariate analysis was performed using the t-test for continuous variables and the c 2 test for proportions.
Multivariable logistic regression was used to identify risk factors for reoperation. Statistical analysis was performed using IBM SPSS Statistics 21.0 software (IBM, Armonk, NY). Two-tailed P < .05 was considered statistically significant.
RESULTS
During the 6-year period, 6677 AAA repairs were registered in the VASQIP database. Of these, 1530 were OR and 5147 were EVAR. Median follow-up time was 4.2 years (range, 1.3-7.3 years). Median follow-up was 4.8 years for OR patients vs 4 years for EVAR. Median time from initial AAA repair to reoperation was 12 days for OR and 63 days for EVAR. Patients receiving EVAR were significantly older and had higher rates of diabetes, functional impairment, history of myocardial infarction, and renal failure (Table II) . Patients receiving OR had a greater proportion of AAA repairs performed at centers averaging <10 cases per year during the 6-year period (15.9% vs 11%; P < .01) and had higher rates of smoking and alcohol abuse. Intraoperatively, OR cases were significantly longer (4.5 6 2 vs 2.9 6 1 hours; P < .01) and more often received blood transfusions >4 units of packed red blood cells (20.4% vs 1.3%; P < .01).
Postoperatively, OR had higher rates of overall combined 30-day complications (26.6% vs 8.9%; P < .01), and specifically, cardiac, respiratory, renal, thromboembolic, and infectious complications. OR recipients required more postoperative blood transfusions >4 units of packed red blood cells (2.1% vs 0.3%; P < .01), had longer hospital lengths of stay (10.1 6 10 vs 3.2 6 5 days; P < .01), 30-day mortality (3.7% vs 1.0%; P < .01), and 1-year mortality (6.0% vs 4.0%; P ¼ .01; Table III) .
At the completion of follow-up, 604 reoperations were performed on 476 patients, of which 214 were after OR and 390 after EVAR. The incidence of at least one reoperation was 10.0% (n ¼ 153) in the OR group and 6.3% (n ¼ 323) in the EVAR group (P < .01). Open vascular reoperation rates were similar between OR and EVAR (2.0% vs 1.9%; P ¼ .81). Endovascular reoperations were significantly higher in the EVAR group (2.8% vs 0.5%; P < .01) as well as groin wound procedures (1.9% vs 0%; P < .01). Abdominal reoperations, including laparotomies, were significantly more common in the OR group (7.1% vs 0.12%; P < .01), as were operations for bowel ischemia (0.7% vs 0.3%; P ¼ .01) and lower extremity ischemia (0.5% vs 0.06%; P < .01; Table IV ). Rates of subcategories of reoperations are summarized in Table IV .
Overall, 44.5% (n ¼ 269) reoperations were performed within 30 days (Table V) . The OR group had significantly higher rates of reoperations compared with EVAR #24 hours (15.9% vs 6.9%; P < .01), #7 days (33.2% vs 18.5%; P < .01), and #30 days (57.5% vs 34.4%; P < .01).
Multivariable regression was performed to evaluate predictors of reoperations, evaluating operative technique as well as preoperative and operative variables shown to be significantly different between OR and EVAR recipients by univariate analysis. Specifically, the variables of greatest clinical interest that were chosen for the statistical model were age, body mass index, history of diabetes, and functional impairment. There were 75 cases with inconsistent coding for nonruptured AAA; therefore, we controlled for this in the multivariable regression. Most of these were EVAR cases that were not listed as ruptured in the primary procedure, however, but had any instance of a diagnosis code for rupture found in their records. This analysis found that EVAR was a negative predictor for reoperation when controlling for preoperative characteristics (P < .01). No other variable was independently predictive of the need for reoperation.
DISCUSSION
Reoperations pose a significant health burden on patients after AAA repair that heavily influences mortality. A review of 2600 patients by Mell et al 4 found that 30-day mortality rose from 1.5% to 22.5% with one reoperation and up to 54% after more than one. Although the long-term risk of reoperation after EVAR is an important limitation, 5 OR may pose a greater reoperative risk than previously thought that persists over the long-term. 6 Abdominal complications make up the largest proportion of reoperations after OR in randomized trials when they are included, 2,3 which was also true in our study, and coincide with greater 30-day and 1-year mortality. Thus, they are crucial to this topic, 7, 8 rendering metaanalysis of recent trials systematically biased.
9,10
The OVER trial, 2 which also evaluated a veteran population, identified 48 incisional hernia repairs required #30 days of OR from 105 reoperations after 437 ORs. There were no cases of adhesiolysis or bowel resection, which are operations that are more likely to be required at a greater time interval. By comparison, our study found that 56% of overall reoperations were required >30 days. These later cases were primarily required due to complications of the abdominal incision, increasing the overall reoperation rates for OR disproportionate to EVAR. Thus, the OVER trial underestimated the reoperations required after OR in this population. Although randomized trial data with more inclusive definitions reported no difference in reoperations rates, our analysis shows higher rates in the OR group, both short-term and long-term. The interpretation of this finding is complex but may be partly due to definitions of reoperations. Substantial effort was made to include all related reoperations, including abdominal wound débridement and reconstructions that were left out of previous studies. We also extended follow-up to the present to capture incisional hernias, bowel obstructions, and abdominal reconstructions that were likely secondary to laparotomy (strictly halting follow-up at the time of any unrelated surgery). The dynamic nature of the EVAR technique likely also plays a role in lower reoperation rates than reported previously. Exclusion of angiograms without further intervention from our study was intended to remove surveillance procedures but may have underestimated examinations indicated for relevant clinical concerns. However, another factor to consider is that EVAR skills and stent graft design continue to improve over time, whereas the OR procedure has not changed recently. Although this has yet to be shown, it would suggest that EVAR reoperations have the potential to decline, which is congruent with our findings.
This study is limited by the retrospective design and reliance on coded data. Although we were able to examine each reoperation procedure and the diagnosis codes, reoperations that were not clearly coded had to be excluded.
Another limitation to our analysis is the absence of information about aortic anatomy. Granted that anatomy often drives the surgical approach, this may confound our analysis due to patients with anatomy unsuitable for EVAR to systematically be assigned to OR. Whether this bias increases reoperations is also unknown. Information regarding previous abdominal operations was not available; thus, the influence on our results is unknown.
Importantly, the Veteran population is predominantly male. Recent literature has recognized that aneurysmal disease in women is not equivalent to disease in men due to potentially more aggressive progression of disease despite the overall lower incidence of AAA. 11 Given this, our findings may not be applicable to the general population.
CONCLUSIONS
The long-term burden of reoperations after OR may actually be more significant than current understanding when all possible abdominal complications are included in an extended analysis. Future prospective trials should include all potential reoperations extended >30 days. As surgical innovation in EVAR technology advances, 
